Loading stock data…
Loading stock data…
US$0.00
Get one email when GBLX crosses your level. Checked every 15 minutes during market hours.
▲ +0.00 (0.00%)up today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
47.7
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.00
Bearish momentumMACD below its signal line (-0.00).
50-day average
0.00
Price belowShort-term trend reference.
200-day average
0.00
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Gb Sciences Inc. is a biotechnology company that predominantly focuses on exploring cannabis-derived therapies for various medical conditions. The primary function of the company is to harness the therapeutic potential of cannabinoids through rigorous scientific research and development processes. Gb Sciences Inc. seeks to transform these natural compounds into medically approved treatments, targeting sectors such as pain management, inflammatory diseases, neurological disorders, and other healt…
www.gbsciences.com| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-02-27 | 0.18 | 0.21 | ✓ Beat |
| 2026-02-03 | 3.32 | 3.33 | ✓ Beat |
| 2025-10-30 | 4.41 | 4.73 | ✓ Beat |
| 2025-10-08 | 0.04 | 0.04 | ✓ Beat |
Companies in the same industry, via Finnhub